<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A comparison was made of the cytokine transcripts in <z:mpath ids='MPATH_458'>normal</z:mpath>, monoclonal, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow aspirates </plain></SENT>
<SENT sid="1" pm="."><plain>While both <z:mpath ids='MPATH_458'>normal</z:mpath> and monoclonal marrow aspirates contain transcripts for SCF, few <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow aspirates contain these transcripts </plain></SENT>
<SENT sid="2" pm="."><plain>Similarly, IL1ra transcripts are found with reduced frequency in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow aspirates </plain></SENT>
<SENT sid="3" pm="."><plain>The fall in SCF transcripts between monoclonal and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow aspirates parallels the appearance of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and the reduced in vitro proliferative ability which are characteristics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow aspirate cells </plain></SENT>
<SENT sid="4" pm="."><plain>The frequent IL1beta production by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow aspirate cells, with few marrow aspirates producing IL1ra transcripts, suggests that unbalanced IL1beta effects may contribute to the proliferative advantage of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cells over their <z:mpath ids='MPATH_458'>normal</z:mpath> counterparts </plain></SENT>
</text></document>